Oncology

Cancer is one of the pioneer causes of obliteration. Although a lot of therapies are being developed in this area but still there is a high unmet need. Currently companies are getting inclined towards Immunotherapies which are target specific (monoclonal and conjugated antibodies) and effective. One such therapy area is Cytotoxic T lymphocyte associated antigen-4 (CTLA-4). It is found on the surface of T –cells and is continuously involved in the inhibitory T-cell responses.CTLA-4  (Cytotoxic T-lymphocyte-associated protein 4), also known as CD152  is a protein receptor that down regulates the immune system by consistently affecting the T cell responses. It is generall...